DelMar Pharmaceuticals, Inc. License Agreements
3 Contracts & Agreements
- Restated and Amended Exclusive License Agreement, effective September 7, 2022, between TuHURA Biopharma, Inc. and West Virginia Research Corporation (Filed With SEC on May 13, 2024)
- Exclusive License Agreement, dated April 23, 2021, between Morphogenesis, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc., as amended (Filed With SEC on May 13, 2024)
- Exclusive License Agreement, dated March 29, 2019, between Morphogenesis, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc., as amended (Filed With SEC on May 13, 2024)
